Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
January 11, 2019	SC 13D/A	An amendment to a SC 13D filing	0001193125-19-007484.pdf 0001193125-19-007484.rtf 0001193125-19-007484.xls View HTML
March 28, 2014	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001144204-14-018572.pdf 0001144204-14-018572.rtf 0001144204-14-018572.xls View HTML
April 3, 2014	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-14-129642.pdf 0001193125-14-129642.rtf 0001193125-14-129642.xls View HTML
May 22, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-178026.pdf 0001193125-17-178026.rtf 0001193125-17-178026.xls View HTML
July 14, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-228620.pdf 0001193125-17-228620.rtf 0001193125-17-228620.xls View HTML
September 26, 2018	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001144204-18-050920.pdf 0001144204-18-050920.rtf 0001144204-18-050920.xls View HTML
June 13, 2014	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-14-236303.pdf 0001193125-14-236303.rtf 0001193125-14-236303.xls View HTML
February 10, 2016	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-16-457756.pdf 0001193125-16-457756.rtf 0001193125-16-457756.xls View HTML
March 6, 2017	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-17-071604.pdf 0001193125-17-071604.rtf 0001193125-17-071604.xls View HTML
January 26, 2018	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-18-021657.pdf 0001193125-18-021657.rtf 0001193125-18-021657.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax